InsiderTrades

Form 4 for IGC IGC Pharma, Inc.

Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0001185185-24-000261 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-15 2024-03-13 IGC PRINS RICHARD K Dir M - OptEx $0.00 +329.6K 1.07M +44% $0
DM 2024-03-15 2024-03-13 IGC PRINS RICHARD K Dir M - OptEx $0.00 -329.6K 100.0K -77% $0
DM 2024-03-15 2024-03-13 IGC PRINS RICHARD K Dir A - Grant $0.00 +385.0K 175.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-13 M A 100,000 $0.00 1,171,667 D — — (F3) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2024.
2 Common Common Stock 2024-03-13 M A 42,750 $0.00 1,214,417 D — — (F4) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
3 Common Common Stock 2024-03-13 M A 28,500 $0.00 1,242,917 D — — (F4) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
4 Common Common Stock 2024-03-13 M A 100,000 $0.00 1,013,334 D — — (F1) On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2022.
5 Common Common Stock 2024-03-13 M A 58,333 $0.00 1,071,667 D — — (F2) On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2023.
6 Derivative Restricted Stock Units 2024-03-13 M D 71,250 $0.00 213,750 D — · — to 2033-03-31 71,250 Common Stock (F4) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock.
7 Derivative Restricted Stock Units 2024-03-13 M D 100,000 $0.00 200,000 D — · — to — 100,000 Common Stock (F3) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2024. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock.
8 Derivative Restricted Stock Units 2024-03-13 M D 58,333 $0.00 58,333 D — · — to — 58,333 Common Stock (F2) On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2023. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock.
9 Derivative Restricted Stock Units 2024-03-13 M D 100,000 $0.00 100,000 D — · — to — 100,000 Common Stock (F1) On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2022. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock.
10 Derivative Restricted Stock Units 2024-03-13 A A 210,000 $0.00 210,000 D — · — to — 210,000 Common Stock (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. (F6) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.
11 Derivative Restricted Stock Units 2024-03-13 A A 175,000 $0.00 175,000 D — · — to 2034-03-31 175,000 Common Stock (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. (F7) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.